Indapamid Stada

Indapamide, the active ingredient in Indapamid Stada, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower elevated blood pressure and to reduce fluid accumulation in patients with heart‑related edema. The medication promotes sodium and water excretion, decreasing peripheral vascular resistance and improving circulatory dynamics.

GNH USA supplies Indapamid Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide. The company provides reliable logistics and regulatory support to ensure timely delivery.

Indapamide acts on the renal distal convoluted tubule to promote diuresis, making it useful in several cardiovascular conditions. - Hypertension: lowers both systolic and diastolic blood pressure, contributing to cardiovascular risk reduction in patients with primary hypertension. - Edema associated with congestive heart failure: enhances sodium and water excretion, decreasing fluid overload and peripheral swelling in heart‑failure patients. - Secondary hypertension: provides additional blood‑pressure control when underlying causes or resistant hypertension limit the effectiveness of other antihypertensive agents.

Indapamide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after the first doses. - Headache: mild to moderate intensity, often transient. - Increased urination: frequent need to void due to diuretic action. - Electrolyte imbalance: mild changes in potassium or sodium levels.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Significant electrolyte disturbances: such as hypokalemia or hyponatremia. - Gout attacks: sudden joint pain due to uric acid elevation. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing Indapamide, clinicians should consider several precautionary measures to ensure safe use. - Monitor electrolytes: regular testing of potassium, sodium and uric acid levels is recommended. - Assess renal function: evaluate kidney performance before initiation and during therapy. - Use caution in hepatic impairment: dose adjustment may be required in patients with liver disease. - Avoid in severe hypotension: the drug can further lower blood pressure in already low readings. - Adjust in diabetes: diuretic‑induced changes in glucose may necessitate monitoring. - Store at room temperature: keep tablets in the original packaging, protect from moisture and direct sunlight.

Indapamide can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Loop diuretics: combined use may cause excessive diuresis and electrolyte loss. - Lithium: increased lithium concentrations can lead to toxicity. - ACE inhibitors or ARBs: additive hypotensive effect may result in marked blood‑pressure drop.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce the diuretic effect of indapamide. - Antidiabetic agents: diuretic‑induced changes in glucose handling may require dose adjustments.